Priceline (PCLN) (ARW) (CL) (AME) (LYB) (CVH) EPS Estimates Changed

Priceline (NASDAQ: PCLN), Arrow Electronics, Inc. (NYSE: ARW), Colgate-Palmolive Company (NYSE: CL), Ametek, Inc. (NYSE: AME), LyondellBasell (NYSE: LYB) and Coventry Health Care, Inc. (NYSE: CVH) had their EPS estimates adjusted by analysts.

UBS AG boosted its EPS estimates on Ametek, Inc. (AME). They have a “Neutral” rating and a price target of $47.00 on the company.

Credit Suisse (NYSE:CS) cut its EPS estimates on Arrow Electronics, Inc. (ARW). They have a “Neutral” rating and a price target $39.00 on the company.

UBS AG (NYSE:UBS) cut its EPS estimates on Colgate-Palmolive Company (CL). They have a “Neutral” rating and a price target of $84.00 on the company.

Barclays Capital raised its EPS estimates on Coventry Health Care, Inc. (CVH). They have an “Equal Weight” rating and a price target of $38.00 on the company.

UBS AG raised its EPS estimates on LyondellBasell (LYB). They have a “Buy” rating and a price target of $47.00 on the company.

ThinkEquity raised its EPS estimates on Priceline (PCLN). They have a “Buy” rating and a price target of $725.00 on the company.

Credit Suisse raised its EPS estimates on Sally Beauty Holdings Inc. (SBH). They have an “Outperform” rating and a price target of $19.00 on the company.

Ametek's (NYSE:AME) Estimates Expected to Go Higher

According to KeyBanc, Ametek Inc. (NYSE:AME) still has room to run in 2011, and they expect estimates to gradually move higher through the year.

KeyBanc said, "AME is one of our top industrial technology ideas for 2011, as we believe there is still a solid amount of "runway" available for estimates to gradually move higher as the year progresses, based upon a combination of factors...We are maintaining our 2010 estimate of $1.73, including a 4Q10 estimate (December) of $0.47 vs. $0.32. Our 2011 estimate remains unchanged at $2.00, and we are establishing an initial 2012 estimate of $2.23. All of our estimates have been adjusted to reflect AME's previously disclosed three-for-two stock split effective in late December 2010. AME is scheduled to report 4Q10 results before the market open on January 27, 2011."

KeyBanc maintains a "Buy" rating on Ametek Inc., which closed Thursday at $39.34, up $0.03, or 0.08 percent. KeyBanc raised their price target on them from $41 to $45.